https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Efepoetin Alfa Noninferior to Mircera When Correcting Anemia, Maintaining Hemoglobin in CKD

Efepoetin Alfa Noninferior to Mircera When Correcting Anemia, Maintaining Hemoglobin in CKD

Patients with chronic kidney disease (CKD) receiving efepoetin alfa demonstrated a response rate of about 75.6%.

administrator

Related Articles